[Patent foramen ovale closure in patients with apoplexia]
Related Experiment Video
Updated: Feb 4, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Anna Gundlund1, Niels Holmark Andersen, Morten Dalsgaard
1annagundlund@gmail.com.
Insights
Patent foramen ovale (PFO) closure reduces stroke recurrence in cryptogenic ischaemic stroke (CIS) patients. Evidence supports PFO closure over antithrombotic therapy alone for these individuals.
Area of Science:
- Cardiology
- Neurology
- Medical Research
Background:
- Patent foramen ovale (PFO) is more common in cryptogenic ischaemic stroke (CIS) patients.
- Previous studies indicated a link between PFO and CIS.
- The role of PFO closure in CIS management has been debated.
Purpose of the Study:
- To review current evidence on PFO closure for CIS.
- To analyze the efficacy of PFO closure versus antithrombotic therapy.
- To propose future recommendations for PFO closure in CIS patients.
Main Methods:
- Systematic review of randomized clinical trials.
- Analysis of stroke recurrence rates.
- Comparison of PFO closure versus antithrombotic therapy outcomes.
Main Results:
- Three 2017 trials demonstrated a benefit of PFO closure in CIS.
- PFO closure significantly lowered stroke recurrence risk compared to antithrombotic therapy alone.
- Patients with CIS and PFO showed improved outcomes with closure.
Conclusions:
- PFO closure is a beneficial therapeutic option for select CIS patients.
- Evidence supports PFO closure over antithrombotic therapy for PFO-positive CIS.
- Future guidelines should consider PFO closure in CIS management.
Abstract:
Epidemiological studies have shown a larger prevalence of patent foramen ovale (PFO) in patients with cryptogenic ischaemic stroke (CIS) than in patients without CIS. In 2017, three randomised clinical trials showed a beneficial effect of PFO closure in patients with CIS. Among patients with CIS and PFO, those who underwent PFO closure, had a lower risk of stroke recurrence than those treated with antithrombotic therapy alone. In this review, we analyse the existing evidence and set up suggestions for future recommendations for PFO closure in patients with CIS.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Patient-centered Care
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Pediatric Patients: Drug Excretion

